The provided documents discuss a 2026 legal action taken by the Federal Trade Commission (FTC) against the telehealth company Hims & Hers. The primary allegations involve deceptive billing practices, where users were charged for subscriptions before receiving a medical review, and the unauthorized sharing of sensitive health data with social media advertising platforms. While the company's asynchronous consultation model is common in the United States, the FTC argues that the specific sequence of payment and consent misled consumers. The text contrasts these American practices with Japanese medical regulations, which strictly require real-time interaction for a valid diagnosis. Ultimately, the source suggests this lawsuit will force telehealth providers to adopt more transparent consent steps and stronger data privacy protections to avoid regulatory penalties.
Podden och tillhörande omslagsbild på den här sidan tillhör
Kazutaka Yoshinaga. Innehållet i podden är skapat av Kazutaka Yoshinaga och inte av,
eller tillsammans med, Poddtoppen.
